Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs
Donald Trump,FDA,Joe Rogan,Robert F Kennedy Jr,Health,Public Health,Drugs,Psychedelics,Executive Orders
President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."
"The executive order I'm signing, we're actually signing the executive order today, is really a moment," Trump said. "These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients."
Related Coverage
AllSides Picks
Recommended Reading
When Trump Goes Out Like a Lion
Dan Schnur
November 9th, 2026
News
Tracking Trumpβs Campaign Promises
AllSides Staff
November 7th, 2026
Headline Roundup
Forensic Expert Says He Believes Epstein Was Murdered After Autopsy Review
November 18th, 2026
Headline Roundup
NSA Confirms Temporary Network Disruption Amid Other Recent Outages
November 17th, 2026